Crossmark Global Holdings Inc. grew its holdings in Relx Plc (NYSE:RELX – Free Report) by 2.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 269,580 shares of the technology company’s stock after buying an additional 5,471 shares during the period. Crossmark Global Holdings Inc.’s holdings in Relx were worth $12,244,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the business. JPMorgan Chase & Co. boosted its holdings in shares of Relx by 14.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock worth $39,225,000 after buying an additional 104,999 shares during the period. CWA Asset Management Group LLC acquired a new position in shares of Relx in the third quarter valued at approximately $548,000. Creative Planning increased its stake in shares of Relx by 16.4% during the second quarter. Creative Planning now owns 128,930 shares of the technology company’s stock worth $5,915,000 after purchasing an additional 18,199 shares during the period. International Assets Investment Management LLC acquired a new stake in Relx during the 3rd quarter worth approximately $1,268,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in Relx by 13.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,300 shares of the technology company’s stock valued at $5,709,000 after purchasing an additional 14,088 shares during the period. 15.02% of the stock is owned by institutional investors and hedge funds.
Relx Trading Up 0.6 %
RELX stock opened at $48.18 on Tuesday. Relx Plc has a 52 week low of $40.25 and a 52 week high of $48.91. The business has a 50-day simple moving average of $46.44 and a 200 day simple moving average of $46.59. The company has a quick ratio of 0.42, a current ratio of 0.48 and a debt-to-equity ratio of 1.63.
Wall Street Analyst Weigh In
Get Our Latest Research Report on Relx
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Stories
- Five stocks we like better than Relx
- How to Use the MarketBeat Stock Screener
- Tech Titans in Chips: 3 Semiconductor Stocks Worth Buying Now
- Election Stocks: How Elections Affect the Stock Market
- Why SoundHound AI’s Setback Could Be a Buying Opportunity
- EV Stocks and How to Profit from Them
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.